Clinical Trial Update: Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of azilsartan on atrial fibrillation in patients with hypertension is ongoing or status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Hypertension

Drugs mentioned

• Azilsartan (azilsartan)

Snippet

Sponsor: Beijing Tsinghua Chang Gung Hospital | Conditions: Hypertension, Atrial Fibrillation | Phase 4 | Status: UNKNOWN